Vaccine Alliance joins the collaborative Access to COVID-19 Tool Accelerator


  • Heather Mason
  • Univadis Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Gavi, the Vaccine Alliance that has been facilitating the development, production and delivery of vaccines worldwide for 20 years, has joined the Access to COVID-19 Tool Accelerator (ACT). This is a collaborative effort by global health organisations aimed at accelerating technologies to fight SARS-CoV-2 by making diagnostics, therapeutics, and vaccines widely available.

Gavi plays a leading role in the response to COVID-19 due to its extensive experience identifying vaccines, innovative financing, ability to work with stakeholders to produce vaccines, and national infrastructures to deliver vaccines. It is currently helping countries during this pandemic by maintaining national immunisation programmes and providing emergency funding for vital supplies and support.

Last week’s announcement will be followed on the 4 May by a major online fundraising event to address financial gaps in the development of new and equitable solutions. These new funds will help the organisation to continue vaccinating children to avoid outbreaks of preventable diseases; to purchase diagnostics, personal protective equipment (PPE) and other vital supplies; and rebuild immunisation systems.

Gavi and ACT hope to provide protection from COVID-19 to everyone worldwide regardless of their economic means since they believe that as long as COVID-19 threatens any country, the entire world is at risk.